B RILEY FINANCIAL INC - RILY 6 3/8 02/28/25 (RILYM)

US05580M8689

23.4  +0.56 (+2.45%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RILYM. RILYM was compared to 218 industry peers in the Capital Markets industry. RILYM may be in some trouble as it scores bad on both profitability and health. RILYM is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

RILYM had negative earnings in the past year.
In the past year RILYM had a positive cash flow from operations.
In multiple years RILYM reported negative net income over the last 5 years.
Of the past 5 years RILYM 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -3.49%, RILYM is not doing good in the industry: 89.30% of the companies in the same industry are doing better.
The Return On Equity of RILYM (-76.26%) is worse than 95.35% of its industry peers.
The Return On Invested Capital of RILYM (1.95%) is worse than 71.63% of its industry peers.
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROIC 1.95%
ROA(3y)0.98%
ROA(5y)2.8%
ROE(3y)-2.83%
ROE(5y)10.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of RILYM (8.23%) is worse than 76.28% of its industry peers.
In the last couple of years the Operating Margin of RILYM has declined.
RILYM has a Gross Margin of 67.58%. This is in the better half of the industry: RILYM outperforms 66.98% of its industry peers.
RILYM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.23%
PM (TTM) N/A
GM 67.58%
OM growth 3Y-31.23%
OM growth 5Y-5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-5.38%

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, RILYM has more shares outstanding
Compared to 5 years ago, RILYM has more shares outstanding
RILYM has a worse debt/assets ratio than last year.

2.2 Solvency

RILYM has an Altman-Z score of -0.11. This is a bad value and indicates that RILYM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.11, RILYM is doing worse than 80.47% of the companies in the same industry.
RILYM has a debt to FCF ratio of 42.28. This is a negative value and a sign of low solvency as RILYM would need 42.28 years to pay back of all of its debts.
RILYM has a worse Debt to FCF ratio (42.28) than 61.40% of its industry peers.
RILYM has a Debt/Equity ratio of 18.53. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 18.53, RILYM is doing worse than 96.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF 42.28
Altman-Z -0.11
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

RILYM has a Current Ratio of 0.22. This is a bad value and indicates that RILYM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.22, RILYM is doing worse than 85.58% of the companies in the same industry.
A Quick Ratio of 0.18 indicates that RILYM may have some problems paying its short term obligations.
RILYM has a worse Quick ratio (0.18) than 86.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.18

3

3. Growth

3.1 Past

The earnings per share for RILYM have decreased strongly by -11.84% in the last year.
The Revenue has grown by 31.31% in the past year. This is a very strong growth!
The Revenue has been growing by 28.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-434.63%
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y28.48%
Sales Q2Q%-15.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RILYM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

73.02% of the companies in the same industry are more expensive than RILYM, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, RILYM is valued a bit cheaper than 78.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.08
EV/EBITDA 16.44

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 41.67%, RILYM is a good candidate for dividend investing.
RILYM's Dividend Yield is rather good when compared to the industry average which is at 9.01. RILYM pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.23, RILYM pays a better dividend.
Industry RankSector Rank
Dividend Yield 41.67%

5.2 History

On average, the dividend of RILYM grows each year by 43.04%, which is quite nice.
RILYM has paid a dividend for less than 5 years, so there is no long track record yet.
RILYM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)43.04%
Div Incr Years0
Div Non Decr Years3

5.3 Sustainability

The earnings of RILYM are negative and hence is the payout ratio. RILYM will probably not be able to sustain this dividend level.
DP-67.91%
EPS Next 2YN/A
EPS Next 3YN/A

B RILEY FINANCIAL INC - RILY 6 3/8 02/28/25

NASDAQ:RILYM (11/22/2024, 8:02:07 PM)

23.4

+0.56 (+2.45%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap709.02M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 41.67%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.23%
PM (TTM) N/A
GM 67.58%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.22
Quick Ratio 0.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y